August 14, 2026 Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(3)
Amendment no. 1 to pricing supplement dated July 9, 2026 to product supplement no. 3-I dated April 17, 2026, underlying supplement no. 1-I dated April 17,
2026 and the prospectus and prospectus supplement, each dated April 17, 2026
JPMorgan Chase Financial Company LLC
Structured Investments
Auto Callable Contingent Interest Notes Linked to the Lesser
Performing of the iShares® Silver Trust and the SPDR® Gold Trust due
July 14, 2031
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in the pricing supplement dated July 9, 2026, related to the notes referred to above
(the "pricing supplement"), the Original Issue Date is as follows:
Original Issue Date (Settlement Date): On or about July 14, 2026
CUSIP: 46661C3B0
Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying
prospectus supplement, "Risk Factors" beginning on page PS-12 of the accompanying product supplement and "Selected
Risk Considerations" beginning on page PS-6 of the pricing supplement.
Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product
supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the related product supplement, underlying supplement,
prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see "Additional Terms
Specific to the Notes" in the pricing supplement.
Pricing supplement dated July 9, 2026:
Product supplement no. 3-I dated April 17, 2026:
Underlying supplement no. 1-I dated April 17, 2026:
Prospectus supplement and prospectus, each dated April 17, 2026: